NFE2L2 and Parkinson disease: Furthermore, supplementation of WDL (37.5 μM) alleviated various stress responses, mitochondrial function, lipid levels, and α-syn deposition to mitigate Parkinson’s disease via the nuclear factor-erythroid 2-related factor 2 (Nrf2)/skinhead-1 (SKN-1) signaling pathway (Sharma et al., 2021).